News
-
-
PRESS RELEASE
Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026
Viromed Medical AG announces ViroCAP® med's successful completion of the regulatory process as a Class IIa medical device, paving the way for market launch at the European Wound Congress 2026. Cold plasma technology for wound treatment -
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Viromed Medical AG missed revenue forecast for 2025 but saw significant growth, achieving a positive result. The company has revised its forecast for 2026 due to market launch delays -
-
PRESS RELEASE
Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH
Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH, marking an exclusive partnership in podiatry with access to over 120,000 customers and preparations for further international sales cooperations -
-
PRESS RELEASE
Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology -
-
